Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) [Phase 2]
Phase II trial evaluating 18F-AV-45 PET imaging in healthy volunteers, mild cognitive impairment, and Alzheimer's disease has completed with…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers [EARLY_Phase 1]
A preliminary Phase 1 study of the amyloid imaging agent 18F-AV-45 (florbetapir F-18) in Alzheimer's disease patients and healthy elderly vo…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers [Phase 1]
Phase 1 study evaluating two doses of the Alzheimer's imaging tracer 18F-AV-45 (florbetapir F-18) in Alzheimer's disease patients and health…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers [Phase 1]
This is a Phase 1 clinical trial update on the PET imaging agent 18F-AV-45 (florbetapir) studied in Alzheimer's disease patients and healthy…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease [Phase 1]
Abbott's ABT-126 was studied in a Phase 1 trial in patients with Alzheimer's disease to assess safety, tolerability, and pharmacokinetics; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: A Study of 18F-AV-45 in Healthy Volunteers [Phase 1]
Phase 1 study of 18F-AV-45 (florbetapir F-18) in healthy volunteers to assess safety and pharmacokinetics; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects
A completed clinical trial evaluating alterations observed by magnetic resonance imaging in elderly subjects with dementia, including Alzhei…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease [Phase 1]
Phase 1 trial evaluating safety and efficacy of NEUROSTEM-AD in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for octohydroaminoacridine succinate tablets in Alzheimer's disease; no results or current trial status are pr…
-
FDA approval · 2012-04-06FDA Approved: AMYVID — Original Application (Eli Lilly and Company)
FDA approved AMYVID (florbetapir F-18) in an original application from Eli Lilly and Company, establishing its use as a PET imaging agent fo…
-
FDA approval · 2012-04-06FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Solco Healthcare US, LLC)
The FDA approved Solco Healthcare US, LLC's supplemental application to market a generic donepezil hydrochloride product for Alzheimer's dis…
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease [Phase 2]
Phase 2 pilot trial of interferon beta-1a for Alzheimer's disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: ELND005 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial update for ELND005 in patients with mild to moderate Alzheimer's disease has completed with results posted in 2012.
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: Memory Disorders Registry
The Memory Disorders Registry study is reported as completed, with conditions including dementia, Alzheimer's disease, Parkinson's disease, …
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease
This document reports the completion of a clinical trial evaluating the safety and effectiveness of galantamine hydrobromide in patients wit…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Non Pharmacological Management of Behavioural Symptoms in Nursing Home [NA]
The clinical trial evaluating non-pharmacological management of behavioral symptoms in Alzheimer's disease in a nursing home setting has bee…
-
CLINICAL_TRIALS research · 2012-03-26Clinical Trial Update: Comparison of 3 Learning Methods to Improve Independent Activities of Daily Living (IADLs) in Alzheimer Disease [NA]
A clinical trial update describing a study that compares three learning methods to improve independence in activities of daily living for pe…
-
CLINICAL_TRIALS research · 2012-03-26Clinical Trial Update: Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers [NA]
Clinical trial update about truncated and extended forms of amyloid beta peptides and their potential as biological markers in Alzheimer’s d…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients [Phase 3]
A Phase 3 trial completed evaluating whether adding rivastigmine to an exercise program improves quality of life in Alzheimer's disease pati…
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: AAB-001 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update for AAB-001 (bapineuzumab) in patients with mild to moderate Alzheimer's disease. The study conducted by Janssen Alzhei…
-
CLINICAL_TRIALS research · 2012-03-09Clinical Trial Update: Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
This study update evaluates how accurately cognitive tests can predict Alzheimer's disease and related cognitive disorders in a diagnostic s…
-
FDA approval · 2012-03-07FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for Aricept (donepezil hydrochloride) from Eisai Inc.
-
FDA approval · 2012-03-07FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc. This action provides an additional app…
-
CLINICAL_TRIALS research · 2012-03-07Clinical Trial Update: Self- Care TALK Study - Promoting Alzheimer's Disease (AD) Spousal Caregiver Health [NA]
Clinical trial update on the Self-Care TALK Study, a self-care intervention aimed at improving health of spouses who care for people with Al…
-
CLINICAL_TRIALS trial_result · 2012-03-05Clinical Trial Update: An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease [Phase 3]
Phase 3 clinical trial evaluating memantine for safety and efficacy in agitated patients with moderate to severe Alzheimer's disease has com…